These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8329728)

  • 1. Assessment of proinsulin's effects on intermediary metabolism using the forearm technique in normal man.
    Davis SN; Monti L; Piatti PM; Ansiferov M; Hetherington C; Brown M; Orskov H; Branch W; Hales CN; Alberti KG
    Acta Diabetol; 1993; 30(1):29-35. PubMed ID: 8329728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of subcutaneous human proinsulin on the production of 64/65 split proinsulin, glucose turnover and intermediary metabolism in non-insulin-dependent diabetic man.
    Davis SN; Piatti PM; Monti L; Brown M; Hetherington C; Antsiferov M; Sobey W; Hales CN; Orskov H; Alberti KG
    Diabetes Res Clin Pract; 1993 Feb; 19(2):103-13. PubMed ID: 8472625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of human proinsulin on glucose turnover and intermediary metabolism in insulin-dependent-diabetes mellitus.
    Davis SN; Ansiferov M; Hetherington C; Brown M; Branch WJ; Hales CN; Orskov H; Alberti KG
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1282-8. PubMed ID: 1430089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of biosynthetic human proinsulin on carbohydrate metabolism.
    Revers RR; Henry R; Schmeiser L; Kolterman O; Cohen R; Bergenstal R; Polonsky K; Jaspan J; Rubenstein A; Frank B
    Diabetes; 1984 Aug; 33(8):762-70. PubMed ID: 6378699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of human proinsulin on glucose turnover and intermediary metabolism.
    Davis SN; Butler PC; Brown M; Beer S; Sobey W; Hanning I; Home PD; Hales CN; Alberti KG
    Metabolism; 1991 Sep; 40(9):953-61. PubMed ID: 1895960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo deactivation of proinsulin action on glucose disposal and hepatic glucose production in normal man.
    Glauber HS; Revers RR; Henry R; Schmeiser L; Wallace P; Kolterman OG; Cohen RM; Rubenstein AH; Galloway JA; Frank BH
    Diabetes; 1986 Mar; 35(3):311-7. PubMed ID: 3512341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response characteristics of human proinsulin and insulin in non-insulin-dependent diabetic humans.
    Davis SN; Monti L; Piatti PM; Brown M; Hetherington C; Orskov H; Sobey W; Hales CN; Alberti KG
    Am J Physiol; 1992 Jul; 263(1 Pt 1):E28-35. PubMed ID: 1636698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of single and combined infusions of human biosynthetic proinsulin and insulin on glucose metabolism and on plasma hormone concentrations in euglycaemic clamp experiments.
    Nauck MA; Stöckmann F; Thiery J; Ebert R; Creutzfeldt W
    Horm Metab Res Suppl; 1988; 18():60-7. PubMed ID: 3056814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective suppression of hepatic glucose output by human proinsulin in the dog.
    Lavelle-Jones M; Scott MH; Kolterman O; Rubenstein AH; Olefsky JM; Moossa AR
    Am J Physiol; 1987 Feb; 252(2 Pt 1):E230-6. PubMed ID: 2881485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a two hour proinsulin infusion on the glucose lowering potency of a following insulin injection.
    Hübinger A; Randerath W; Tosetti P; Schlüter KJ; Gries FA
    Horm Metab Res Suppl; 1988; 18():34-7. PubMed ID: 3056809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of free fatty acids on glucose uptake and nonoxidative glycolysis across human forearm tissues in the basal state and during insulin stimulation.
    Yki-Järvinen H; Puhakainen I; Koivisto VA
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1268-77. PubMed ID: 2026747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole body and regional fuel metabolism during early postexercise recovery.
    Devlin JT; Barlow J; Horton ES
    Am J Physiol; 1989 Jan; 256(1 Pt 1):E167-72. PubMed ID: 2643339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forearm substrate exchange during hyperinsulinaemic hypoglycaemia in normal man.
    Abildgaard N; Orskov L; Petersen JA; Alberti KG; Schmitz O; Møller N
    Diabet Med; 1995 Mar; 12(3):218-23. PubMed ID: 7758257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased hepatic glucagon responses in type 1 (insulin-dependent) diabetes mellitus.
    Orskov L; Alberti KG; Mengel A; Møller N; Pedersen O; Rasmussen O; Seefeldt T; Schmitz O
    Diabetologia; 1991 Jul; 34(7):521-6. PubMed ID: 1916058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of carnitine with insulin-stimulated glucose metabolism in humans.
    Ferrannini E; Buzzigoli G; Bevilacqua S; Boni C; Del Chiaro D; Oleggini M; Brandi L; Maccari F
    Am J Physiol; 1988 Dec; 255(6 Pt 1):E946-52. PubMed ID: 3059823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of proinsulin pretreatment on the combined actions of insulin and proinsulin in normal man.
    Glauber HS; Wallace P; Galloway J; Frank BH; Olefsky JM
    J Clin Endocrinol Metab; 1986 Apr; 62(4):785-8. PubMed ID: 3512594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GLP-1 does not not acutely affect insulin sensitivity in healthy man.
    Orskov L; Holst JJ; Møller J; Orskov C; Møller N; Alberti KG; Schmitz O
    Diabetologia; 1996 Oct; 39(10):1227-32. PubMed ID: 8897012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of hormonal counterregulation during GCIIS-guided hypoglycemia tests using human proinsulin and human insulin (recombinant DNA).
    Müller-Esch G; von der Lühe C; Ball P; Henkel E; Schlüter KJ; Wood WG; Scriba PC
    Horm Metab Res Suppl; 1988; 18():24-33. PubMed ID: 2847967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral and hepatic insulin sensitivity in subjects with impaired glucose tolerance.
    Berrish TS; Hetherington CS; Alberti KG; Walker M
    Diabetologia; 1995 Jun; 38(6):699-704. PubMed ID: 7672492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise-induced changes in insulin and glucagon are not required for enhanced hepatic glucose uptake after exercise but influence the fate of glucose within the liver.
    Pencek RR; James FD; Lacy DB; Jabbour K; Williams PE; Fueger PT; Wasserman DH
    Diabetes; 2004 Dec; 53(12):3041-7. PubMed ID: 15561932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.